Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 27, 2009

Thermo Fisher Scientific to Pay $125M for Biolab

  • Thermo Fisher Scientific plans on acquiring Biolab for A$175 million, or approximately $125 million. Thermo Fisher Scientific thus expands its operations into Australia, New Zealand, and the South Pacific.

    Biolab is the scientific and medical division of Alesco. It reportedly has annual revenues of about A$170 million, or $121 million. The firm supplies lab products, analytical instruments, and services to the bioscience, medical, industrial biotech, and environmental industries.

    “As the premier commercial channel in Australia, New Zealand, and the South Pacific, Biolab offers a broad portfolio of products and services to support Thermo Fisher’s continued growth in the region,” notes Marijn E. Dekkers, president and CEO of Thermo Fisher Scientific. “This acquisition significantly strengthens our presence in these markets and will enable us to better serve customers in both public and private sectors through an expanded range of offerings.”

    The transaction is expected to be completed on April 30. The company will be integrated into Thermo Fisher’s laboratory products and services segment.


    ---

    Past Thermo Fisher Scientific Acquisitions
    Thermo Fisher Scientific Takes Over Affinity BioReagents to Bolster Proteomics Offerings (July 17, 2008)
    Thermo Fisher Scientific Takes Over Open Biosystems (July 1, 2008)
    Thermo Fisher Scientific Bolsters India Presence with Acquisition of Chemito Franchises (June 3, 2008)
    Thermo Fisher Scientific Gobbles Up German Firm (Dec. 20, 2007)
    Thermo Fisher Scientific Acquires NanoDrop Technologies (Oct. 10, 2007)



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »